Ken Griffin Horizon Therapeutics Public LTD CO Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $31 Million - $36.3 Million	-313,276 Reduced 7.02%	4,149,825 $480 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $46.7 Million - $54.5 Million	485,092 Added 12.19%	4,463,101 $459 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $291 Million - $308 Million	2,712,069 Added 214.23%	3,978,009 $434 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $91.3 Million - $167 Million	-1,463,094 Reduced 53.61%	1,265,940 $144 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $134 Million - $193 Million	2,275,125 Added 501.23%	2,729,034 $169 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $22.1 Million - $32.4 Million	278,543 Added 158.84%	453,909 $36.2 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $89.9 Million - $114 Million	-1,039,961 Reduced 85.57%	175,366 $18.5 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $58.5 Million - $71.2 Million	-593,822 Reduced 32.82%	1,215,327 $131 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $7.06 Million - $8.47 Million	76,786 Added 4.43%	1,809,149 $198 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $66.8 Million - $74.3 Million	774,230 Added 80.81%	1,732,363 $162 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $22.9 Million - $30.5 Million	319,243 Added 49.97%	958,133 $88.2 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $43.3 Million - $54.5 Million	-646,067 Reduced 50.28%	638,890 $46.7 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $132 Million - $192 Million	-2,397,293 Reduced 65.1%	1,284,957 $99.8 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $2.55 Million - $4.82 Million	84,598 Added 2.35%	3,682,250 $205 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $55.5 Million - $86 Million	2,230,627 Added 163.17%	3,597,652 $107 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $22.1 Million - $31.8 Million	867,360 Added 173.59%	1,367,025 $49.5 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $15.7 Million - $19.1 Million	-681,806 Reduced 57.71%	499,665 $13.6 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $26.9 Million - $33.6 Million	1,181,471 New	1,181,471 $28.4 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account